Acción 6118 AUSTAR LIFESCIENCES LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Austar Lifesciences Limited

Acciones

6118

KYG0632L1023

Mercado cerrado - Hong Kong S.E.
Otros sitios de cotización
 10:08:20 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
0,82 HKD -7,87 % Gráfico intradía de Austar Lifesciences Limited -18,00 % -47,44 %
26/03 Austar Lifesciences Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023 CI
22/01 Austar Lifesciences sufrirá pérdidas; las acciones caen MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Austar Lifesciences to Swing to Loss; Shares Drop
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
Austar Lifesciences Hires New Auditor
Austar Lifesciences Swings to Loss in H1
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2023
ValGenesis, Inc. and AUSTAR Group Partner to Deploy Digital, Risk-Based Solutions for Life Sciences Companies in China
Austar Lifesciences Expects Higher Loss in H1
Austar Lifesciences Limited Updates Consolidated Group Earnings Guidance for the Six Months Ending June 30, 2023
Austar Lifesciences Warns of H1 Loss
Austar Lifesciences Limited Provides Group Earnings Guidance for the Six Months Ending 30 June 2023
Austar Lifesciences Announces 2022 Annual Results
Austar Lifesciences Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Austar Lifesciences Expects 2022 Profit to Fall to 50 Million Yuan
Austar Lifesciences Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022
Austar Lifesciences Limited Announces Executive Changes
Austar Lifesciences Limited(SEHK:6118) dropped from S&P Global BMI Index
Austar Lifesciences Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Austar Lifesciences Forecasts H1 Profit Fall to $6.4 Million
Austar Lifesciences Limited acquired an unknown minority interest in Noozle Fluid Technology Co., Ltd..
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 6118
  4. Noticias Austar Lifesciences Limited
  5. Otros idiomas